Showing 161 - 180 results of 14,280 for search '(( 50 ((((ng decrease) OR (we decrease))) OR (nn decrease)) ) OR ( 16 b decrease ))', query time: 0.45s Refine Results
  1. 161

    Supplementary Material for: Decreasing Trend in Incidence of Late Onset Culture Positive Bloodstream Infections but Not Late Onset Meningitis in Preterm Infants <33 Weeks Gestation... by Zhou Q. (4138852)

    Published 2021
    “…<b><i>Introduction:</i></b> Recent studies reported decreased incidence of late onset sepsis in the neonatal intensive care unit (NICU), but it is unclear whether this is also true for late onset meningitis. …”
  2. 162
  3. 163

    <b>Exploration of S-ECC microbiota through a novel developed nutrient enriched microbiological medium, high through-put 16S rRNA sequencing and culturomics-</b><b>Sequence Data</b> by 艺欣 张 (17564160)

    Published 2024
    “…</p><p><br></p><p dir="ltr"><b>Results:</b></p><p dir="ltr">Either NEMM or SHI medium showed a significant decrease in bacterial alpha diversity compared to clinical dental plaque samples by high throughput 16S rRNA sequencing analysis, indicating a larger room for the improvement of both media. …”
  4. 164
  5. 165
  6. 166
  7. 167
  8. 168
  9. 169
  10. 170

    Discovery of the Triazolo[1,5‑<i>a</i>]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming Multidrug Resistance... by Shuai Wang (109515)

    Published 2021
    “…Targeting P-glycoprotein (ABCB1 or P-gp) has been recognized as a promising strategy to overcome multidrug resistance. Here, we reported our medicinal chemistry efforts that led to the discovery of the triazolo­[1,5-<i>a</i>]­pyrimidine derivative <b>WS-898</b> as a highly effective ABCB1 inhibitor capable of reversing paclitaxel (PTX) resistance in drug-resistant SW620/Ad300, KB-C2, and HEK293/ABCB1 cells (IC<sub>50</sub> = 5.0, 3.67, and 3.68 nM, respectively), more potent than verapamil and zosuquidar. …”
  11. 171

    Discovery of the Triazolo[1,5‑<i>a</i>]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming Multidrug Resistance... by Shuai Wang (109515)

    Published 2021
    “…Targeting P-glycoprotein (ABCB1 or P-gp) has been recognized as a promising strategy to overcome multidrug resistance. Here, we reported our medicinal chemistry efforts that led to the discovery of the triazolo­[1,5-<i>a</i>]­pyrimidine derivative <b>WS-898</b> as a highly effective ABCB1 inhibitor capable of reversing paclitaxel (PTX) resistance in drug-resistant SW620/Ad300, KB-C2, and HEK293/ABCB1 cells (IC<sub>50</sub> = 5.0, 3.67, and 3.68 nM, respectively), more potent than verapamil and zosuquidar. …”
  12. 172
  13. 173
  14. 174

    Effect of citric acid on melanogenesis and tyrosinase activity in B16F10, HMV-II, and HEM. by Siqi Zhou (5750777)

    Published 2020
    “…The melanin content increased in mouse cells (B16F10) and decreased in human cells (HMV-II and HEM). …”
  15. 175

    The effect of citric acid on the viability and proliferation of B16F10, HMV-II, and HEM cells. by Siqi Zhou (5750777)

    Published 2020
    “…<p>B16F10, HMV-II, and HEM cells were treated with citric acid (CA). …”
  16. 176
  17. 177
  18. 178
  19. 179
  20. 180